Laboratory Corp. of America Holdings(0JSY)
USD --+0.00%
Reward38Moderate
Risk46Moderate
📊75%Data
0JSY
+0.0 · +0.00%
USD · LSE
Laboratory Corp. of America Holdings |
Structurally Challenged
Market Cap:
ℹ️
Reward Rating
38
Moderate
Bottom 5% (model universe)
75% data coverage
ℹ️
Risk Rating
46
Moderate
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on 0JSY to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Laboratory Corp. of America Holdings?

It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services.

0JSY · Verdict

Limited reward · moderate risk

0JSY's standout is cash flow; growth and profitability weigh on the picture.

Based on 88% data coverage

0JSY · Verdict

What’s working & what to watch

Strengths 1

  • Cash flow72/100

    9% free-cash-flow margin

Watchouts 3

  • Growth32/100

    Rev +5.6% CAGR · earnings -11.8%

  • Profitability36/100

    6% net margin · 11% ROE

  • Valuation40/100

    Below average

Model-based scoring. For information only — not financial advice.

What is Laboratory Corp. of America Holdings?

It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C, PSA, tests for sexually transmitted diseases, vitamin D testing, microbiology cultures and procedures, and alcohol and other substance abuse tests. The company is listed on the LSE in UK, and a P/E ratio of 0.1x.

Financial Highlights

Investment Breakdown

📈 Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
💰 Profitability
Thin or inconsistent margins weigh on earnings quality.
⚠️ Risk
Risk profile appears balanced versus broad market conditions.
💸 Valuation
Premium valuation reflects strong growth expectations already priced in.

OpenBook Logo Analysis

Reward: Moderate (38)

The scoring profile indicates weak reward characteristics across most factors, including momentum and size. Risk indicators are moderate, consistent with typical market exposure.

For informational purposes only. Not financial advice.

Company Information
SectorN/A
Market CapN/A
P/E Ratio0.1182
Dividend Yield1.11%
52 Week High296.5431
52 Week Low236.3825
Last AnnualDecember
IPO DateN/A
IncorporatedUK
Shares Outstanding101M
No. of Employees61,770
IndustryN/A
ExchangeLSE
Beta0.985
CurrencyUSD